Target intelligence / Profile preview

Long intergenic non-protein coding RNA 670 (LINC00670)

Target
LINC00670
Molecular classification
Long non-coding RNA (lncRNA), Other
01

Overview

Long intergenic non-protein coding RNA 670 (LINC00670), also known as CARDINAL, is a cardiac-specific long non-coding RNA located upstream of the myocardin (MYOCD) gene on chromosome 17. Approximately 2.8 kb in length and comprised of four exons, LINC00670 is notable for its enrichment in heart tissue and conservation in mice[4][1]. It acts through multiple mechanisms: in the nucleus, it interacts with the transcription factor serum response factor (SRF) to antagonize mitogenic gene transcription, while in the cytoplasm, it associates with ribosomes to modulate protein translation[1][4]. LINC00670 plays a critical role in attenuating cardiac hypertrophy and balancing cardiac gene expression, and its dysregulation exacerbates systolic dysfunction following myocardial infarction[4][1]. Recent studies indicate that LINC00670 (CARDINAL) may also serve as a potential biomarker and therapeutic target in certain cancers, such as gastric cancer[3], highlighting its emerging significance in both cardiovascular disease and oncology.

Other names
CARDINALFLJ34690cardiac lncRNA transcribed adjacent to myocardin
02

Mechanism of action

Regulation of cardiac hypertrophy through modulation of ribosome association and interaction with serum response factor (SRF); influences severity of heart failure and cardiac hypertrophy; possible roles in cancer cell regulation

03

Biological functions

Regulation of cardiac hypertrophyModulation of protein translationTranscriptional regulation (via SRF interaction)Regulation of mitogenic gene transcription
04

Disease associations

Cardiovascular diseaseCancer (including roles in prognosis and treatment in gastric cancer and possible association with other cancers)
05

Safety considerations

No prominent direct safety concerns identifiedtherapeutic challenges may include tissue specificity and potential off-target effects
06

Biomarkers

Potential marker for prognosis in gastric cancer and as a therapeutic target in heart failure/cardiac hypertrophy

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 670 (LINC00670).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 670 (LINC00670).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call